Chemesis International Forum: Community User: markus456

Nix wie raus. Das Geld ist sonst verloren Leute.

Immer dasselbe Spiel...

Nur ein kleiner Sprung?

JosefMiez, die Meldung ist schon neu. Letzte Woche wurde der Einspruch gemeldet und die Lizenzen waren ausgesetzt. Ab heute ist das wieder vom Tisch. Ich hätte mit einem stärkeren Anstieg mit dieser Nachricht gerechnet, aber die Anleger sind mittlerweile stark verunsichert. Hier muss erst wieder Vertrauen geschaffen werden!

Allerdings darf man nicht fie ganzen Optionen vergessen, die sie rausgehauen haben.

Ok👍

Der Link reicht doch!

https://www.accesswire.com/575266/Chemesis-International-Inc-Provides-Corporate-Update

CHEMESIS INTERNATIONAL INC. PROVIDES CORPORATE UPDATE Further to the news release dated Jan. 27, 2020, the Puerto Rico Department of Health (DHPR), as a result of the previously announced favourable judgment from the Puerto Rico Superior Court, San Juan (please see the news release dated Jan. 17, 2020), has reinstated all cannabis cultivation and cannabis manufacturing licences, held by Chemesis International Inc.'s subsidiary, Natural Ventures PR LLC. The decision, which is still under appeal, found that such abeyance of the licences was invalid and unconstitutional, and nullified such action. The company noted that, at the current time, the licences have been reinstated to being operational, and that Natural Ventures is permitted to carry out the licensed activities under the licences. The company will provide further updates, as appropriate. About Chemesis International Inc. Chemesis is a vertically integrated U.S. multistate operator with international operations in Puerto Rico and Colombia. Chemesis has facilities in both Puerto Rico and California. The company is positioned to win additional licences in highly competitive merit-based U.S. states and will expand its footprint to ensure it maintains a first-mover advantage.

Abwarten

-95%

This is a huge bullshit stock

VANCOUVER, BC / ACCESSWIRE / January 27, 2020 / Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the "Company" or "Chemesis"), announces, further to its news release dated January 17, 2019, that the Puerto Rico Department of Health has commenced an appeal of the favourable judgment (the "Decision") obtained by the Company from the Puerto Rico Superior Court, San Juan, in respect of the certain cannabis licenses ("Licenses") held by its subsidiary, Natural Ventures PR, LLC ("Natural Ventures") which had effectively been abeyed by the Puerto Rico Department of Health. The Decision, which is now under appeal, found that such abeyance of the Licenses was invalid and unconstitutional and nullified such action. The Company notes that the Department of Health had applied for a order staying the effect of the Decision until the appeal has been heard and decided; however, the Court decided in favour of the Company and did not stay the effect of the Decision. As a result, the Company remains in active consultation with its legal team with a view to having the Decision implemented as soon as practicable. The Company notes that, at the current time, the Licenses have not yet been reinstated to being operational, and that Natural Ventures is still not permitted to carry out any licensed activities under the Licenses, though it is permitted to carry out certain activities for the purposes of preserving and maintaining inventory. The Company will provide further updates as appropriate.

Nur mal zur Info, bisher keine Antwort von der PR erhalten.

🥳🥳 es geht weiter aufwärts

VANCOUVER, BC / ACCESSWIRE / January 23, 2020 / Chemesis International Inc. (CSE:CSI)(OTCQB:CADMF)(FRA:CWAA) (the "Company" or "Chemesis"), is pleased to announce that it has completed its previously-announced private placement ("Private Placement") of 16,393,444 units ("Units") at a price of CDN $0.305 per Unit. Each Unit is comprised of one common share and one common share purchase warrant (the "Warrants"). Each Warrant is exercisable for one common share at a price of CDN $0.405 for a period of 24 months. The Company also announces that it has entered into debt settlement agreements with certain convertible debenture holders and other creditors, pursuant to which it has discharged an aggregate total indebtedness of CDN $1,884,996, on the following bases: CDN $1,485,831 owing under a convertible debenture has been repaid in cash. CDN $284,444 owing under a convertible debenture has been repaid through the issuance of 406,348 units of the Company (the "Debt Settlement Units"), with each Debt Settlement Unit being comprised of one common share and one common share purchase warrant (the "Debt Settlement Warrants") and issued at a deemed price of CDN $0.70. Each Debt Settlement Warrant is exercisable for one common share at a price of CDN $0.70 for a period of 24 months. CDN $114,691 owed to a creditor was settled through the issuance of 163,844 Debt Settlement Units. In addition, the Company has also completed its previously announced convertible debt settlement (see news release dated January 14, 2019) whereby it has had discharged a total indebtedness of CDN $1,109,440 under certain convertible debentures through the issuance of 1,232,711 units of the Company (the "Debt Conversion Units"), with each Debt Conversion Unit being comprised of one common share and one common share purchase warrant (the "Debt Conversion Warrants") and issued at a deemed price of CDN $0.90. Each Debt Conversion Warrant is exercisable for one common share at a price of CDN $1.12 for a period of 24 months. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States of America. The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States of America absent registration or an applicable exemption from registration requirements.